Endoscopic subserosal dissection for gastric tumors: 18 cases in a single center

Surg Endosc. 2022 Nov;36(11):8039-8046. doi: 10.1007/s00464-022-09229-3. Epub 2022 Apr 19.

Abstract

Background: Endoscopic submucosal dissection has technical limitations for the resection of gastric epithelial tumors with severe fibrosis and mixed or exophytic gastric subepithelial tumors (SETs).

Aims: To analyze the safety and effectiveness of endoscopic subserosal dissection (ESSD) for tumors growing in the subserosal space.

Methods: This observation study enrolled 18 patients who were diagnosed with gastric tumors and underwent ESSD at the Presbyterian Medical Center from 2010 to March 2019.

Results: A total of 18 patients were treated by ESSD. The mean age of the patients was 61.7 years. The mean length of the long axis of the tumor was 18.0 ± 5.0 mm. The mean operation time was 44 (range 11-167) min. The pathologic diagnosis was leiomyoma in nine cases (50.0%), gastrointestinal stromal tumor in six (33.3%), low-grade adenoma with severe fibrosis in two (11.1%), and schwannoma in one (5.6%). There were three cases of perforation, which were treated conservatively. The complete resection rate was 94%, and local or systemic tumor recurrence was not seen in a mean 70 months of follow-up.

Conclusion: ESSD can be used for epithelial tumors with severe fibrosis and mixed or exophytic gastric SETs in the lesser curvature, cardia, or fundus that cannot be treated using standard methods.

Keywords: Dissection; Gastrointestinal stromal tumors; Stomach.

Publication types

  • Observational Study

MeSH terms

  • Endoscopic Mucosal Resection* / methods
  • Fibrosis
  • Gastric Mucosa / surgery
  • Gastrointestinal Stromal Tumors* / surgery
  • Gastroscopy / methods
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology
  • Neoplasms, Glandular and Epithelial* / pathology
  • Retrospective Studies
  • Stomach Neoplasms* / pathology
  • Stomach Neoplasms* / surgery
  • Treatment Outcome